Aquestive Therapeutics, Inc. (AQST)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 01:58PM EDT. Market open.
| Previous close | 3.3800 |
| Open | 3.1800 |
| Bid | 3.0300 x 200 |
| Ask | 3.0700 x 100 |
| Day's range | 2.9100 - 3.2300 |
| 52-week range | 1.2510 - 6.2300 |
| Volume | |
| Avg. volume | 2,891,039 |
| Market cap | 278.66M |
| Beta (5Y monthly) | 2.91 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics
The headline numbers for Aquestive Therapeutics (AQST) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- Zacks
Aquestive Therapeutics (AQST) Reports Q1 Loss, Misses Revenue Estimates
Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of -88.89% and 1.37%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last?
Verrica Pharmaceuticals (VRCA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
© 2024 Yahoo. All rights reserved.